- Home
- GIII vs RCUS Comparison
GIII vs RCUS Comparison
Compare GIII & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIII
- RCUS
- Stock Information
- Founded
- GIII 1956
- RCUS 2015
- Country
- GIII United States
- RCUS United States
- Employees
- GIII 4600
- RCUS N/A
- Industry
- GIII Apparel
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- GIII Consumer Discretionary
- RCUS Health Care
- Exchange
- GIII Nasdaq
- RCUS Nasdaq
- Market Cap
- GIII 1.4B
- RCUS 1.4B
- IPO Year
- GIII 1989
- RCUS 2018
- Fundamental
- Price
- GIII $31.39
- RCUS $13.75
- Analyst Decision
- GIII Hold
- RCUS Buy
- Analyst Count
- GIII 7
- RCUS 12
- Target Price
- GIII $33.29
- RCUS $34.50
- AVG Volume (30 Days)
- GIII 521.4K
- RCUS 583.4K
- Earning Date
- GIII 03-13-2025
- RCUS 02-19-2025
- Dividend Yield
- GIII N/A
- RCUS N/A
- EPS Growth
- GIII N/A
- RCUS N/A
- EPS
- GIII 3.78
- RCUS N/A
- Revenue
- GIII $3,106,043,000.00
- RCUS $263,000,000.00
- Revenue This Year
- GIII $3.70
- RCUS $127.65
- Revenue Next Year
- GIII $2.02
- RCUS N/A
- P/E Ratio
- GIII $8.24
- RCUS N/A
- Revenue Growth
- GIII N/A
- RCUS 119.17
- 52 Week Low
- GIII $20.66
- RCUS $13.51
- 52 Week High
- GIII $36.18
- RCUS $20.31
- Technical
- Relative Strength Index (RSI)
- GIII 43.82
- RCUS 36.52
- Support Level
- GIII $30.07
- RCUS $13.81
- Resistance Level
- GIII $31.88
- RCUS $14.45
- Average True Range (ATR)
- GIII 1.10
- RCUS 0.54
- MACD
- GIII -0.17
- RCUS -0.06
- Stochastic Oscillator
- GIII 44.67
- RCUS 18.05
About GIII G-III Apparel Group LTD.
G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists primarily of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives most of its revenues from Wholesale operations.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.